Evidence map›Paper›PMID 18508118›Full record

ArticleBiomaterials

Development of photocrosslinked sialic acid containing polymers for use in Abeta toxicity attenuation.

Christopher B Cowan, Gerard L Coté, Theresa A Good

Open access · greenAbstract read
In one paragraph

Article in Biomaterials. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Christopher B CowanChemical and Biochemical Engineering, University of Maryland, Baltimore County, UMBC 1000 Hilltop Circle, Baltimore, MD 21250, USA.
Gerard L Coté
Theresa A Good
University of Maryland, Baltimore County · USTexas A&M University · US

Funding

Use of Sialic Acid Containing Polymers in Alzheimer'sR21NS050346 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI GOOD, THERESA ANN · 2005 to 2006
$317k
NINDS NIH HHS R21 NS050346
6 · The paper itself

Abstract

beta-Amyloid peptide (Abeta), the primary protein component in senile plaques associated with Alzheimer's disease (AD), has been implicated in neurotoxicity associated with AD. Previous studies have shown that the Abeta-neuronal membrane interaction plays a crucial role in Abeta toxicity. More specifically, it is thought that Abeta interacts with ganglioside rich and sialic acid rich regions of cell surfaces. In light of such evidence, we have hypothesized that the Abeta-membrane sialic acid interaction could be inhibited through use of a biomimic multivalent sialic acid compound that would compete with the cell surface for Abeta binding. To explore this hypothesis, we synthesized a series of photocrosslinked sialic acid containing oligosaccharides and tested their ability to bind Abeta and attenuate Abeta toxicity in cell culture assays. We show that a polymer prepared via the photocrosslinking of disialyllacto-N-tetraose (DSLNT) was able to attenuate Abeta toxicity at low micromolar concentrations without adversely affecting the cell viability. Polymers prepared from mono-sialyl-oligosaccharides were less effective at Abeta toxicity attenuation. These results demonstrate the feasibility of using photocrosslinked sialyl-oligosaccharides for prevention of Abeta toxicity in vitro and may provide insight into the design of new materials for use in attenuation of Abeta toxicity associated with AD.

Indexed as

Amyloid beta-PeptidesAnimalsCell Line, TumorCell SurvivalCross-Linking ReagentsMolecular StructureN-Acetylneuraminic AcidOligosaccharidesPolymersSpectroscopy, Fourier Transform InfraredAmyloid beta-PeptidesCross-Linking ReagentsN-Acetylneuraminic AcidOligosaccharidesPolymers

Identifiers

PMID18508118
PMCPMC2587107
OpenAlexW2134965509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.